Quantum Biopharma Stock Alpha and Beta Analysis

QNTM Stock   3.94  0.26  6.19%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Quantum BioPharma. It also helps investors analyze the systematic and unsystematic risks associated with investing in Quantum BioPharma over a specified time horizon. Remember, high Quantum BioPharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Quantum BioPharma's market risk premium analysis include:
Beta
1.78
Alpha
(1.01)
Risk
9.66
Sharpe Ratio
(0.09)
Expected Return
(0.82)
Please note that although Quantum BioPharma alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Quantum BioPharma did 1.01  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Quantum BioPharma stock's relative risk over its benchmark. Quantum BioPharma has a beta of 1.78  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Quantum BioPharma will likely underperform. At this time, Quantum BioPharma's Enterprise Value Over EBITDA is very stable compared to the past year. As of the 10th of February 2026, Price Book Value Ratio is likely to grow to 0.34, while Net Current Asset Value is likely to drop (51.3 K).

Enterprise Value

(1.08 Million)

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Quantum BioPharma Analysis, Quantum BioPharma Valuation, Quantum BioPharma Correlation, Quantum BioPharma Hype Analysis, Quantum BioPharma Volatility, Quantum BioPharma Price History and analyze Quantum BioPharma Performance.
To learn how to invest in Quantum Stock, please use our How to Invest in Quantum BioPharma guide.

Quantum BioPharma Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Quantum BioPharma market risk premium is the additional return an investor will receive from holding Quantum BioPharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Quantum BioPharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Quantum BioPharma's performance over market.
α-1.01   β1.78

Quantum BioPharma expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Quantum BioPharma's Buy-and-hold return. Our buy-and-hold chart shows how Quantum BioPharma performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Quantum BioPharma Market Price Analysis

Market price analysis indicators help investors to evaluate how Quantum BioPharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Quantum BioPharma shares will generate the highest return on investment. By understating and applying Quantum BioPharma stock market price indicators, traders can identify Quantum BioPharma position entry and exit signals to maximize returns.

Quantum BioPharma Return and Market Media

The median price of Quantum BioPharma for the period between Wed, Nov 12, 2025 and Tue, Feb 10, 2026 is 7.43 with a coefficient of variation of 24.98. The daily time series for the period is distributed with a sample standard deviation of 1.89, arithmetic mean of 7.55, and mean deviation of 1.52. The Stock received some media coverage during the period.
 Price Growth (%)  
       Timeline  
1
Can Quantum BioPharma Ltd. stock deliver strong Q4 earnings - Weekly Trade Recap Intraday High Probability Alerts - newser.com
11/17/2025
2
Can Quantum BioPharma Ltd. stock resist broad market declines - 2025 Year in Review Daily Stock Trend Reports - Newser
12/04/2025
3
Bronstein, Gewirtz Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act Class Action Filed Alleging Investor Harm - morningstar.com
12/26/2025
4
FinancialContent - Kaplan Fox Alerts Quantum Biopharma Ltd. Investors to a Securities Class Action Lawsuit - Deadline is February 23, 2026 - FinancialContent
01/06/2026
5
Quantum BioPharma Heads For Best Week Ever But Most Retail Traders Lament Missing Out On The Surge - MSN
01/09/2026
6
iFIT and Huge Launch Realms You Cant Reach, a New Category of Cinematic Fitness Experiences Built With AI
01/21/2026
7
Bronstein, Gewirtz Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act Class Action Filed Alleging Investor Harm
01/26/2026
8
CONTACT INVESTOR ALERT Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadl...
01/27/2026

About Quantum BioPharma Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Quantum or other stocks. Alpha measures the amount that position in Quantum BioPharma has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2010 2025 2026 (projected)
Payables Turnover0.610.550.49
Days Of Inventory On Hand126.96114.26101.57

Quantum BioPharma Investors Sentiment

The influence of Quantum BioPharma's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Quantum. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Quantum BioPharma's public news can be used to forecast risks associated with an investment in Quantum. The trend in average sentiment can be used to explain how an investor holding Quantum can time the market purely based on public headlines and social activities around Quantum BioPharma. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Quantum BioPharma's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Quantum BioPharma's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Quantum BioPharma's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Quantum BioPharma.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Quantum BioPharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Quantum BioPharma's short interest history, or implied volatility extrapolated from Quantum BioPharma options trading.

Build Portfolio with Quantum BioPharma

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Quantum BioPharma is a strong investment it is important to analyze Quantum BioPharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Quantum BioPharma's future performance. For an informed investment choice regarding Quantum Stock, refer to the following important reports:
Check out Quantum BioPharma Analysis, Quantum BioPharma Valuation, Quantum BioPharma Correlation, Quantum BioPharma Hype Analysis, Quantum BioPharma Volatility, Quantum BioPharma Price History and analyze Quantum BioPharma Performance.
To learn how to invest in Quantum Stock, please use our How to Invest in Quantum BioPharma guide.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Quantum BioPharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Quantum BioPharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Quantum BioPharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...